関連する実験動画
Updated: May 10, 2026

11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.9K
新しい WRN 阻害剤の高通量評価
Haiyan Xu1, Rachel L Palte2, Meredith M Rickard2
1Dept of Quantitative Biosciences, Merck Research Laboratories Discovery, Preclinical and Translational Medicine, Merck & Co. Inc., Rahway, NJ, USA.
SLAS discovery : advancing life sciences R & D
|August 27, 2025
まとめ
ワーナー症候群ヘリケーズ (WRN) をターゲットにすることで,マイクロサテライト不安定性 (MSI-H) がんの治療に新しい戦略が提供されます. WRNを阻害することで,MSI-H腫瘍細胞のDNA修復の脆弱性を利用し,新しいがん治療法への道を開きます.
科学分野:
- 腫瘍学
- 分子生物学
- 薬物の発見
背景:
- ゲノムの安定性はDNA修復メカニズムによって維持されます.
- ワーナー症候群ヘリコース (WRN) は,DNA二重鎖破裂 (DSB) の修復に不可欠であり,マイクロサテライト不安定性高い (MSI-H) 癌の治療標的である.
- MSI-H腫瘍はDNA不一致修復の欠陥を示し,生存のためにWRNに依存しています.
研究 の 目的:
- MSI-H がん治療のための新しい WRN 阻害剤を特定し,開発する.
- 微衛星安定 (MSS) 腫瘍細胞に対するWRN阻害の有効性と選択性を評価する.
- コンピュータモデリングと実験的測定を組み合わせた知識に基づく薬剤発見アプローチを活用する.
主な方法:
- in vitro生化学測定法 (ATPase,ヘリカゼ) と細胞ベースの測定法 (生命性,標的の関与) を利用した.
- MSI-H細胞における致死性を確認するために,CRISPR媒介のWRNノックアウトを使用した.
- DNA DSBバイオマーカー (pH2AX) の検出と標的の誘導のためのセルラー熱シフトアッセイを適用した.
- 統合された計算モデリングとスクリーニングの取り組み (フェノタイプ,ALIS,ADP glo HTS,DEL)
主要な成果:
- WRNのCRISPRノックアウトは,MSI-H細胞では致命的だったが,MSS細胞では致命的ではなかった.
- MSI-H腫瘍細胞を標的とする新種のスパイロサイクルWRN阻害剤が発見されました.
- 開発された阻害剤は,WRNヘリケーゼを誘導する効能と選択性を示した.
結論:
- WRNはMSI-Hがんの有効な治療標的である.
- WRNの標的抑制は選択的ながん治療のための有望な戦略です.
- 新しい治療薬の開発には学際的なアプローチが不可欠です
さらに関連する動画
関連する概念動画
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

